121 related articles for article (PubMed ID: 26731993)
1. High Expression of IncRNA-PCNA-AS1 in Human Gastric Cancer and its Clinical Significances.
Dang Y; Wang Y; Ouyang X; Wang L; Huang Q
Clin Lab; 2015; 61(11):1679-85. PubMed ID: 26731993
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
3. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance.
Lin X; Yang M; Xia T; Guo J
Med Oncol; 2014 Jul; 31(7):42. PubMed ID: 24984296
[TBL] [Abstract][Full Text] [Related]
5. Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.
Yuan SX; Tao QF; Wang J; Yang F; Liu L; Wang LL; Zhang J; Yang Y; Liu H; Wang F; Sun SH; Zhou WP
Cancer Lett; 2014 Jul; 349(1):87-94. PubMed ID: 24704293
[TBL] [Abstract][Full Text] [Related]
6. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375.
Quan Y; Zhang Y; Lin W; Shen Z; Wu S; Zhu C; Wang X
Biochem Biophys Res Commun; 2018 Mar; 497(2):527-534. PubMed ID: 29428732
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer.
Li Y; Wen X; Wang L; Sun X; Ma H; Fu Z; Li L
Surg Oncol; 2017 Dec; 26(4):527-534. PubMed ID: 29113674
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between ZEB1-AS1 Expression and the Prognosis of Patients With Advanced Gastric Cancer Receiving Chemotherapy.
Chai H; Sun C; Liu J; Sheng H; Zhao R; Feng Z
Technol Cancer Res Treat; 2019 Jan; 18():1533033819849069. PubMed ID: 31072267
[TBL] [Abstract][Full Text] [Related]
11. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
[TBL] [Abstract][Full Text] [Related]
12. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
[TBL] [Abstract][Full Text] [Related]
13. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G
Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170
[TBL] [Abstract][Full Text] [Related]
14. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer.
Yang Y; Shao Y; Zhu M; Li Q; Yang F; Lu X; Xu C; Xiao B; Sun Y; Guo J
Tumour Biol; 2016 Jan; 37(1):1183-8. PubMed ID: 26280398
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.
Chen M; Wu X; Ma W; Zhou Q; Wang X; Zhang R; Wang J; Yang X
Cancer Biomark; 2017 Dec; 21(1):23-28. PubMed ID: 29036784
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer.
Moazzen H; Rajabi A; Safaralizadeh R
Pathol Res Pract; 2023 Aug; 248():154639. PubMed ID: 37364417
[TBL] [Abstract][Full Text] [Related]
18. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
Yang M; Zhai X; Xia B; Wang Y; Lou G
Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
